Live tape
Top 8, mentions 7d29,227NVDA13,827 mentions▲ +0.04ANT4,203 mentions▲ +0.07GOOGL2,995 mentions▲ +0.04SPY2,294 mentions▲ +0.05QQQ1,806 mentions▲ +0.04SPCX1,568 mentions▲ +0.07AMD1,364 mentions▲ +0.06AAPL1,170 mentions▲ +0.04

Equity · Healthcare

EW

NYSE

Edwards Lifesciences (EW)

101.88 USD −1.93% vs prior close Nov 20, 2026
Edwards Lifesciences Corporation price graph
64 sessions
110 80 24 Aug 20 Nov

The line runs 90.51 USD on 24 August through 101.88 USD on 20 November, on a scale from 80 to 110. Days the market did not trade hold the previous close, flat.

Market cap
58.6B USD
P/E (TTM)
57.6
Revenue, year to Dec 2025
6.1B USD
EPS, diluted, year to Dec 2025
1.83 USD
52-week range
75.82 USD – 107.19 USD
Avg volume
295.9K
Mentions, 30 days
5
Net sentiment
+0.04

as of Nov 20, 2026

Have Edwards Lifesciences (EW) insiders bought or sold shares recently?

In the 90 days to 23 Nov 2026, Edwards Lifesciences insiders reported 9 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 11 Mar 2026, show no open-market purchase.

Form 4, 90 days to 23 Nov 2026, newest reported trade 10 Nov 2026

0buys
9sells
$10.89Mnet sold
11other filings
Have Edwards Lifesciences (EW) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
10 Nov 2026Lippis Daniel J.CVP, TAVRSell61965K USD
09 Nov 2026BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSell48,9005.0M USD
09 Nov 2026Zovighian Bernard JCEOSell23,1002.4M USD
08 Oct 2026Lippis Daniel J.CVP, TAVRSell61953K USD
11 Sep 2026Lippis Daniel J.CVP, TAVRSell61954K USD
31 Aug 2026Dahl Andrew M.SVP, Corporate ControllerSell54450K USD
28 Aug 2026Bruls AnnetteCVP, EMEACLASell2,644238K USD
26 Aug 2026Chopra DaveenCVP, TMTT, Surgical & IHFMSell31,8002.9M USD
26 Aug 2026Markowitz WayneCVP, JAPACSell1,240113K USD
Sold9 open-market sales110,085$10.89M
11 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Edwards Lifesciences (EW) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
13 Nov 2026Dahl Andrew M.SVP, Corporate ControllerTax withheld10111K USD
10 Nov 2026Lippis Daniel J.CVP, TAVROption exercise61945K USD
09 Nov 2026BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOption exercise48,9003.6M USD
09 Nov 2026Zovighian Bernard JCEOOption exercise23,1001.7M USD
08 Oct 2026Lippis Daniel J.CVP, TAVROption exercise61945K USD
14 Sep 2026Markowitz WayneCVP, JAPACTax withheld56848K USD
13 Sep 2026Dahl Andrew M.SVP, Corporate ControllerTax withheld25321K USD
11 Sep 2026Markowitz WayneCVP, JAPACTax withheld35531K USD
11 Sep 2026Chopra DaveenCVP, TMTT, Surgical & IHFMTax withheld39835K USD
11 Sep 2026Lippis Daniel J.CVP, TAVROption exercise61945K USD
26 Aug 2026Chopra DaveenCVP, TMTT, Surgical & IHFMOption exercise31,8002.3M USD

Which funds hold Edwards Lifesciences (EW)?

12 of the 45 institutional funds we track reported a Edwards Lifesciences position for the quarter ended 30 Sep 2026 — a combined 1.2B USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Edwards Lifesciences (EW)?
FundPositionSharesValueShares q/q
Millennium ManagementAdded5,835,006503.7M USD+62.8%
Citadel AdvisorsTrimmed2,396,906206.9M USD−40.0%
AQR Capital ManagementAdded1,950,840167.4M USD+33.1%
Balyasny Asset ManagementAdded1,335,899115.3M USD+192.8%
Man GroupHeld (±25%)1,086,91493.8M USD+16.2%
Point72 Asset ManagementTrimmed899,48577.6M USD−49.3%
Bridgewater AssociatesAdded408,07235.2M USD+48.2%
Two Sigma InvestmentsTrimmed191,41716.5M USD−87.4%
Renaissance TechnologiesAdded104,9009.1M USD+399.5%
Fisher Asset ManagementHeld (±25%)80,5036.9M USD−8.3%

Showing the 10 largest of 12 reported positions. The figures above count all of them.

Have members of Congress traded Edwards Lifesciences (EW)?

The most recent congressional trade disclosed in Edwards Lifesciences is a sale by Josh Gottheimer (house, NJ), dated 19 Nov 2025.

STOCK Act disclosures

Have members of Congress traded Edwards Lifesciences (EW)?
TradedMemberTypeAmountFiled after
19 Nov 2025Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD40 days
21 Apr 2025Bruce Westermanhouse · Republican–ARSale1K USD–15K USD21 days
08 Apr 2025Robert P. Bresnahan, Jr.house · Republican–PAPurchase1K USD–15K USD30 days
03 Mar 2025Bruce Westermanhouse · Republican–ARPurchase1K USD–15K USD44 days
11 Apr 2024Mike Kellyhouse · Republican–PASale1K USD–15K USD64 days
11 Dec 2023Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD27 days
04 Dec 2023John R. Curtissenate · Republican–UTSale1K USD–15K USD11 days
21 Jun 2023John R. Curtissenate · Republican–UTPurchase1K USD–15K USD47 days

Edwards Lifesciences (EW) US federal contracts

US federal agencies committed 29.4M USD in contracts to Edwards Lifesciences (EW) in fiscal 2026, the year to 30 Sep 2026, against 27.9M USD the year before.

USAspending.gov

2.9MUSDfiscal 2027 so far
29.4MUSDfiscal 2026
27.9MUSDfiscal 2025
27.3MUSDfiscal 2024
Edwards Lifesciences (EW) US federal contracts
SignedAgencyContractCommitted
19 Nov 2026Department of Veterans AffairsCUSTOM SURGICAL IMPLANTSMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C26027P0081204K USD
18 Nov 2026Department of Veterans AffairsSURGICAL IMPLANTMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C26127P0154102K USD
12 Nov 2026Department of Veterans AffairsSURGICAL IMPLANTMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C26127P0109172K USD
05 Nov 2026Department of Veterans AffairsPROSTHETICS - SURGICAL IMPLANTMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C26127P0085102K USD
27 Oct 2026Department of Veterans AffairsTAVR HEART VALVESMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C24127P0051136K USD
21 Oct 2026Department of Veterans AffairsPASCALMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C26127P0041115K USD
15 Oct 2026Department of Veterans AffairsCUSTOM SURGICAL IMPLANTSMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C26027P0042102K USD
08 Oct 2026Department of Veterans AffairsCUSTOM SURGICAL IMPLANTSMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C26027P0038102K USD
30 Sep 2026Department of Veterans AffairsEXPRESS REPORT: HEART VALVESMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C25526K0278232K USD
29 Sep 2026Department of Veterans AffairsEDWARDS CONSIGNMENT - SURGICAL IMPLANTS EO 14398MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C25026N0911198K USD

Newest first: 10 of 184 contracts. Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.

What has been filed or recorded for Edwards Lifesciences (EW)?

The filings we hold for Edwards Lifesciences, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 29 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Edwards Lifesciences (EW)?
And
29 Oct 2026Fails to deliverShares failed to deliver61 shares6K USD notional · <0.001% of shares out
22 Oct 2026Fails to deliverShares failed to deliver179 shares16K USD notional · <0.001% of shares out
20 Oct 2026Fails to deliverShares failed to deliver171 shares15K USD notional · <0.001% of shares out
14 Oct 2026Fails to deliverShares failed to deliver18 shares2K USD notional · <0.001% of shares out
13 Oct 2026Fails to deliverShares failed to deliver47 shares4K USD notional · <0.001% of shares out
09 Oct 2026Fails to deliverShares failed to deliver47 shares4K USD notional · <0.001% of shares out
08 Oct 2026Fails to deliverShares failed to deliver47 shares4K USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 0.53 USDRevenue $1.72B
30 Sep 2026FinancialsTotal assets14.1B USDat period end
30 Sep 2026FinancialsTotal equity10.9B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 0.42 USDRevenue $1.74B
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 0.66 USDRevenue $1.65B
31 Dec 2025Annual reportFY 2025 reportedEPS 1.83 USDRevenue $6.07B
31 Dec 2025FinancialsRevenue6.1B USDfiscal year
31 Dec 2025FinancialsNet income1.1B USDfiscal year
31 Dec 2025FinancialsDiluted EPS1.83 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 0.50 USDRevenue $1.55B
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 0.56 USDRevenue $1.53B
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 0.61 USDRevenue $1.41B
31 Dec 2024Annual reportFY 2024 reportedEPS 0.65 USDRevenue $1.39B

What is Reddit saying about Edwards Lifesciences (EW)?

Reddit mentioned EW 5 times in the 30 days to 22 November 2026, across 3 of the communities we track. All of them were scored for sentiment: 60% read bullish, 0% bearish and 40% neither. Reddit data updated 22 November 2026.

30-day window, Method

5mentions, 30 days
60%bullish
0%bearish
3communities
+8pointsagainst the market

How do Reddit mentions of Edwards Lifesciences (EW) compare with its price?

Share ↗
5 mentions

Which subreddits are talking about Edwards Lifesciences (EW)?

30 days

Which subreddits are talking about Edwards Lifesciences (EW)?
CommunityShareMentionsNet sentiment
r/stocks60%3+0.05
r/etfs20%1+0.05
r/wallstreetbets20%1+0.01

What do people ask about Edwards Lifesciences (EW)?

From live data
What did Edwards Lifesciences shares close at?101.88

Edwards Lifesciences closed at 101.88 USD on 20 Nov 2026, down 1.93% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Edwards Lifesciences’ market cap?58.6B

Edwards Lifesciences is worth 58.6B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Edwards Lifesciences’ P/E ratio?57.6

Edwards Lifesciences has a price-to-earnings ratio of 57.6, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is Edwards Lifesciences’ revenue?6.1B

Edwards Lifesciences reported revenue of 6.1B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Edwards Lifesciences insiders bought or sold shares recently?9 sales

In the 90 days to 23 Nov 2026, Edwards Lifesciences insiders reported 9 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 11 Mar 2026, show no open-market purchase. A further 11 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Edwards Lifesciences?12 of 45

12 of the 45 funds we track reported a Edwards Lifesciences position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Citadel Advisors and AQR Capital Management. See Funds

Have members of Congress traded Edwards Lifesciences?17 trades

Yes. 17 trades in Edwards Lifesciences appear in the congressional disclosures we hold; the latest is a sale by Josh Gottheimer (House, NJ) dated 19 Nov 2025, filed 29 Dec 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did Edwards Lifesciences last report earnings?0.53

Edwards Lifesciences last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.53 USD; no next date is announced in SEC filings yet. See Filings

Does Edwards Lifesciences have government contracts?29.4M

Yes. US federal agencies committed 29.4M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts

What is Reddit saying about Edwards Lifesciences?0 mentions

Edwards Lifesciences was mentioned 0 times in the last 7 days across the finance subreddits we track, and 5 times over the trailing 30 days. Of the 5 mentions scored for sentiment, 60% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. Wikimedia CommonsPortraits via Wikimedia Commons. John R. Curtis: United States House of Representatives Office of Photography, Public domain; Bruce Westerman: United States Congress, Public domain; Josh Gottheimer: Kristie Boyd; U.S. House Office of Photography, Public domain; Mike Kelly: US House of Representatives, Public domain; Robert P. Bresnahan, Jr.: House Creative Services, Public domain.
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
  9. SECSEC fails-to-deliver (CNS) data
  10. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  11. SEC EDGARreported earnings figures and scheduled report dates
  12. SEC EDGARValuation computed from SEC EDGAR filings
  13. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words